irritable bowel conditions | sciencenewsnet.in

Breaking News

Do we think and feel Alike? field evidence on developing a shared reality when dealing with service robots

Enhancing trust in online grocery shopping through generative AI chatbots

Partner or servant? The influence of robot role positioning on consumers’ brand evaluations

Artificial intelligence and consumer behavior: From predictive to generative AI

Black, Hispanic, and American Indian adolescents likelier than white adolescents to be tested for drugs, alcohol at pediatric trauma centers

Research points to potential new treatment for aggressive prostate cancer subtype

Impact of pollutants on pollinators, and how neural circuits adapt to temperature changes

UMD Alumna Kim Rice DeGross Joins Smith as Office of Career Services Assistant Dean

Atmospheric Observatory Opens for Operation in Bankhead National Forest

Dana-Farber Cancer Institute delivers ‘simple immediate impact’ to patient comfort using weighted blankets

06 Oct, 2024

Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as New Treatment Option Shows Good Results in Clinical Trial

September 25, 2024 sarah JonasResearch Results

A phase 2 trial of a monoclonal antibody known as tulisokibart for moderate-to-severe ulcerative colitis (UC) showed promising results for those who have not responded to conventional inflammatory bowel disease (IBD) treatment. The results were reported Thursday, September 26, in The New England Journal of Medicine.

All FODMAPs aren’t created equal: working toward alternative diets to manage IBS

July 17, 2024 sarah JonasResearch Results

Two studies from Michigan Medicine may provide hope for patients with irritable bowel syndrome struggling to implement the traditional low-FODMAP diet.